UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 188

Sortiert nach

ROCK2 Inhibition With Belumosudil (KD025) for the Treatment of Chronic Graft-Versus-Host Disease

Journal of clinical oncology, 2021-06, Vol.39 (17), p.1888-1898

2021

Volltextzugriff (PDF)

Epidemiology and Treatment of Chronic Graft-versus-Host Disease Post-Allogeneic Hematopoietic Cell Transplantation: A US Claims Analysis

Transplantation and cellular therapy, 2021-06, Vol.27 (6), p.504.e1-504.e6

2021

Volltextzugriff (PDF)

Belumosudil for Chronic Graft-Versus-Host Disease (cGVHD) after 2 or More Prior Lines of Therapy: The Rockstar Study (KD025-213)

Blood, 2020-11, Vol.136 (Supplement 1), p.45-46

2020

Volltextzugriff (PDF)

Cost-effectiveness of adding carfilzomib to lenalidomide and dexamethasone in relapsed multiple myeloma from a US perspective

Journal of medical economics, 2016-11, Vol.19 (11), p.1061-1074

2016

Volltextzugriff (PDF)

Venous thromboembolism prophylaxis in medical ICU patients in Asia (VOICE Asia): A multicenter, observational, cross-sectional study

Thrombosis research, 2012-04, Vol.129 (4), p.e152-e158

2012

Volltextzugriff (PDF)

Assessment of baseline characteristics, glycemic control and oral antidiabetic treatment in Asian patients with diabetes: The Registry for Assessing OAD Usage in Diabetes Management (REASON) Asia study (在亚洲糖尿病患者中评估基线特征、血糖控制情况以及口服降糖药物使用情况：使用登记表评估糖尿病治疗中口服药使用情况（REASON）的亚洲研究)

Journal of diabetes, 2013-09, Vol.5 (3), p.309-318

2013

Volltextzugriff (PDF)

Effect of nitric oxide production on the redox modulatory site of the NMDA receptor-channel complex

Neuron (Cambridge, Mass.), 1992-06, Vol.8 (6), p.1087-1099

1992

Volltextzugriff (PDF)

Severe GI Toxicities Remain a Significant Source of Clinical Meaningful Morbidity Especially in Older Patients Receiving Autologous Transplant for Lymphoma

Blood, 2021-11, Vol.138 (Supplement 1), p.4899-4899

2021

Volltextzugriff (PDF)

Epidemiology and Real-World Treatment of Chronic Graft-Versus-Host Disease Post Allogeneic Hematopoietic Cell Transplantation: A US Claims Analysis

Blood, 2019-11, Vol.134 (Supplement_1), p.2109-2109

2019

Volltextzugriff (PDF)

Results of a Phase 1 Open Label Dose Escalation Trial of AB-205 (Allogeneic Engineered Endothelial Cell Therapy) in Adults with Lymphoma Undergoing High-Dose Therapy and Autologous Hematopoietic Cell Transplantation (HDT-AHCT)

Blood, 2020-11, Vol.136 (Supplement 1), p.14-15

2020

Volltextzugriff (PDF)

KD025 for Patients with Chronic Graft-Versus-Host Disease (cGVHD) - Long-Term Follow-up of a Phase 2a Study (KD025-208)

Blood, 2019-11, Vol.134 (Supplement_1), p.872-872

2019

Volltextzugriff (PDF)

Cardiac Events in Real-World Multiple Myeloma Patients Treated with Carfilzomib: A Retrospective Claims Database Analysis

Blood, 2016-12, Vol.128 (22), p.3319-3319

2016

Volltextzugriff (PDF)

Once-Weekly Carfilzomib with Dexamethasone Demonstrated Promising Safety and Efficacy in Patients with Relapsed or Refractory Multiple Myeloma Regardless of Age and Prior Bortezomib Exposure

Blood, 2016-12, Vol.128 (22), p.2129-2129

2016

Volltextzugriff (PDF)

KD025-208: A Phase 2a Study of KD025 for Patients with Chronic Graft Versus Host Disease (cGVHD) — Pharmacodynamics and Updated Results

Blood, 2018-11, Vol.132 (Supplement 1), p.602-602

2018

Volltextzugriff (PDF)

Demographic and Comorbidity Characteristics of Newly Diagnosed Multiple Myeloma Patients in the United States: A Real World Data Analysis

Blood, 2014-12, Vol.124 (21), p.1301-1301

2014

Volltextzugriff (PDF)

Belumosudil for Chronic Graft-Versus-Host Disease (cGVHD) after 2 or More Prior Lines of Therapy: The Rockstar Study (KD025-213)

Transplantation and cellular therapy, 2021-03, Vol.27 (3), p.S7-S8

2021

Volltextzugriff (PDF)

Assessment of baseline characteristics, glycemic control and oral antidiabetic treatment in A sian patients with diabetes: The R egistry for A ssessing OAD U sage in D iabetes M anagement ( REASON ) A sia study (在亚洲糖尿病患者中评估基线特征、血糖控制情况以及口服降糖药物使用情况：使用登记表评估糖尿病治疗中口服药使用情况（REASON）的亚洲研究)

Journal of diabetes, 2013-09, Vol.5 (3), p.309-318

2013

Volltextzugriff (PDF)

KD025 for Patients with Chronic Graft-Versus-Host Disease (cGVHD) – Long-Term Follow-up of a Phase 2a Study (KD025-208)

Biology of blood and marrow transplantation, 2020-03, Vol.26 (3), p.S187-S188

2020

Volltextzugriff (PDF)

KD025-208: A Phase 2a Study of KD025 for Patients with Chronic Graft Versus Host Disease (cGVHD) - Pharmacodynamics (PD) and Updated Results

Biology of blood and marrow transplantation, 2019-03, Vol.25 (3), p.S28-S29

2019

Volltextzugriff (PDF)

Micro-actuators for high density disk drives

Proceedings of the 1997 American Control Conference (Cat. No.97CH36041), 1997, Vol.6, p.3979-3984 vol.6

1997

Volltextzugriff (PDF)

Eya protein phosphatase activity regulates Six1-Dach-Eya transcriptional effects in mammalian organogenesis

Nature, 2003-11, Vol.426 (6964), p.247-254

2003

Volltextzugriff (PDF)

Epidemiology of Congenital Rubella Syndrome (CRS) in India, 2016-18, based on data from sentinel surveillance

PLoS neglected tropical diseases, 2020-02, Vol.14 (2), p.e0007982-e0007982

2020

Volltextzugriff (PDF)

Serum protein signature of coronary artery disease in type 2 diabetes mellitus

Journal of translational medicine, 2019-01, Vol.17 (1), p.17-17, Article 17

2019

Volltextzugriff (PDF)

1 – 25 von 188

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(155)
Mit Volltextzugriff
(172)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(104)
Life Sciences & Biomedicine
(80)
Humans
(69)
Male
(40)
Female
(39)
Adult
(29)
India
(28)
Middle Aged
(23)
Technology
(19)
Aged
(17)
Medicine
(16)
Young Adult
(14)
Adolescent
(13)
Public Health
(13)
India - Epidemiology
(12)
Risk Factors
(12)
Child
(11)
General & Internal Medicine
(10)
Medicine & Public Health
(10)
Public, Environmental & Occupational Health
(10)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

ROCK2 Inhibition With Belumosudil (KD025) for the Treatment of Chronic Graft-Versus-Host Disease

Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study

Genome-Wide Association Study for Type 2 Diabetes in Indians Identifies a New Susceptibility Locus at 2q21

Epidemiology and Treatment of Chronic Graft-versus-Host Disease Post-Allogeneic Hematopoietic Cell Transplantation: A US Claims Analysis

Belumosudil for Chronic Graft-Versus-Host Disease (cGVHD) after 2 or More Prior Lines of Therapy: The Rockstar Study (KD025-213)

Cost-effectiveness of adding carfilzomib to lenalidomide and dexamethasone in relapsed multiple myeloma from a US perspective

Venous thromboembolism prophylaxis in medical ICU patients in Asia (VOICE Asia): A multicenter, observational, cross-sectional study

Effect of nitric oxide production on the redox modulatory site of the NMDA receptor-channel complex

Severe GI Toxicities Remain a Significant Source of Clinical Meaningful Morbidity Especially in Older Patients Receiving Autologous Transplant for Lymphoma

Epidemiology and Real-World Treatment of Chronic Graft-Versus-Host Disease Post Allogeneic Hematopoietic Cell Transplantation: A US Claims Analysis

Results of a Phase 1 Open Label Dose Escalation Trial of AB-205 (Allogeneic Engineered Endothelial Cell Therapy) in Adults with Lymphoma Undergoing High-Dose Therapy and Autologous Hematopoietic Cell Transplantation (HDT-AHCT)

KD025 for Patients with Chronic Graft-Versus-Host Disease (cGVHD) - Long-Term Follow-up of a Phase 2a Study (KD025-208)

Cardiac Events in Real-World Multiple Myeloma Patients Treated with Carfilzomib: A Retrospective Claims Database Analysis

Once-Weekly Carfilzomib with Dexamethasone Demonstrated Promising Safety and Efficacy in Patients with Relapsed or Refractory Multiple Myeloma Regardless of Age and Prior Bortezomib Exposure

KD025-208: A Phase 2a Study of KD025 for Patients with Chronic Graft Versus Host Disease (cGVHD) — Pharmacodynamics and Updated Results

Demographic and Comorbidity Characteristics of Newly Diagnosed Multiple Myeloma Patients in the United States: A Real World Data Analysis

Belumosudil for Chronic Graft-Versus-Host Disease (cGVHD) after 2 or More Prior Lines of Therapy: The Rockstar Study (KD025-213)

KD025 for Patients with Chronic Graft-Versus-Host Disease (cGVHD) – Long-Term Follow-up of a Phase 2a Study (KD025-208)

KD025-208: A Phase 2a Study of KD025 for Patients with Chronic Graft Versus Host Disease (cGVHD) - Pharmacodynamics (PD) and Updated Results

Micro-actuators for high density disk drives

Eya protein phosphatase activity regulates Six1-Dach-Eya transcriptional effects in mammalian organogenesis

Epidemiology of Congenital Rubella Syndrome (CRS) in India, 2016-18, based on data from sentinel surveillance

Serum protein signature of coronary artery disease in type 2 diabetes mellitus

Suchergebnisse filtern